Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Market Closed - Nyse
Other stock markets
 21:30:00 07/06/2024 BST 		5-day change 1st Jan Change
1.45 USD +5.84% Intraday chart for NKGen Biotech, Inc. -13.17% -82.53%
06-03 NKGen Biotech, Inc. To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 CI
05-23 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. News NKGen Biotech, Inc.
  6. Transcripts
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW